Current Edition

Europe

MLM Medical Labs and Cenetron Central Laboratories Announce Strategic Alliance

Central laboratories expand transcontinental reach with integrated services Moenchengladbach, Germany and Austin, Texas, USA - November 11, 2015 MLM Medica...
Continue Reading →
news

NeuroGenetic Pharmaceuticals Awarded $2.5 Million Grant From NIA to Conduct Clinical Trials with NGP 555 to Treat and Prevent Alzheimer’s Disease; Reports Initial Results of Phase 1a Clinical Trial

SAN DIEGO/November 10, 2015 --(BUSINESS WIRE)--NeuroGenetic Pharmaceuticals, Inc. (NGP), a privately held biopharmaceutical company focused on Alzheimer’s disease (AD...
Continue Reading →
Europe

SynteractHCR to Share Insights on the New EU Clinical Trials Regulation at 2015 Partnerships in Clinical Trials Europe

SAN DIEGO/November 10, 2015 --(BUSINESS WIRE)--Full-service contract research organization (CRO) SynteractHCR will share its Phase I-IV clinical trials expertise as w...
Continue Reading →
news

Greenphire Appoints Jim Murphy as CEO

King of Prussia, PA/ November 9, 2015 – Greenphire, the leading provider of payment technology for the clinical trials industry, today announced the appointment of Ji...
Continue Reading →
news

CRF Health’s TrialMax App Withstands Scrutiny of Usability and Comparability Testing

Plymouth Meeting, PA – October 27, 2015:  CRF Health, the leading global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences ind...
Continue Reading →
news

FDA Solicits mHealth, Wearable Tech Info For Clinical Trials

The U.S. Food and Drug Administration (FDA) is seeking input from relevant stakeholders on how new technologies — including mobile health technology (mHealth), teleme...
Continue Reading →
Europe

Scottish Child Cancer Patients Missing out on Clinical Trials

CHILD cancer patients in Scotland are missing out on experimental treatments due to a lack of clinical trials, a study has found. Research presented at the National C...
Continue Reading →
news

CluePoints and Widler & Schiemann Collaborate on Complete Risk-Management Solution for Clinical Trials in Line with New Industry Guidance

Partnership will combine CluePoints' Risk-Based Monitoring Software with Widler & Schiemann's Consultancy Services 2 November 2015 Cambridge, MA - CluePoints, a l...
Continue Reading →
news

Macrocure (MCUR) Phase III Clinical Trial of CureXcell Missed Primary Endpoint

Macrocure Ltd. (NASDAQ: MCUR) today announced that results from a pivotal Phase 3 multicenter, randomized, double-blind, parallel-group, sham-controlled study (MC-102...
Continue Reading →
news

16 First Time Endovascular Clinical Trial Results to be presented at VIVA 15

LAS VEGAS, Oct. 27, 2015 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervent...
Continue Reading →